From pathogenesis to precision medicine in systemic lupus erythematosus: Emerging biomarkers and targeted interventions
Weiya Lan, Qianwei Lu, Zong Jiang, Wukai Ma, Lei Hou, Danyang Li, Xudong Rui, Fang Tang · 2026
Read From pathogenesis to precision medicine in systemic lupus erythematosus: Emerging biomarkers and targeted interventions by Weiya Lan, Qianwei Lu, Zong Jiang, Wukai Ma, Lei Hou, Danyang Li, Xudong Rui, Fang Tang (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13141465.txt.
Description
SummarySystemic lupus erythematosus (SLE) is a chronic, systemic autoimmune disease characterized by immune dysregulation, autoantibody production, and chronic inflammation, which can potentially damage almost any organ. The estimated worldwide prevalence of SLE ranges from 5 to 7 million, and it is associated with significant morbidity, premature death, and significant global disparities in terms of sex, ethnicity/race, and geography.
Catalog record
| CREATOR | Weiya Lan, Qianwei Lu, Zong Jiang, Wukai Ma, Lei Hou, Danyang Li, Xudong Rui, Fang Tang |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 100 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |